Mice crippled with MS are made to walk again with breakthrough cure

Scientists astonished by spectacular results

John von Radowitz
Thursday 15 May 2014 20:09
Comments
Within 10 to 14 days, the mice had regained motor skills and were able to walk again
Within 10 to 14 days, the mice had regained motor skills and were able to walk again

Treatment with human stem cells has allowed mice crippled by a version of multiple sclerosis (MS) to walk again after less than two weeks – suggesting a possible new direction for human therapies.

Scientists admit to being astonished by the result and believe it opens up a new avenue of research in the quest for solutions to MS.

Professor Tom Lane, from the University of Utah, who led the US team, recalled: “My postdoctoral fellow Dr Lu Chen came to me and said, ‘The mice are walking.’ I didn’t believe her.”

The genetically engineered mice had a condition that mimics the symptoms of human MS.

They were so disabled they could not stand long enough to eat and drink on their own and had to be hand-fed.

The scientists transplanted human neural stem cells into the animals, expecting them to be rejected and provide no benefit. Instead the experiment yielded spectacular results.

Within 10 to 14 days, the mice had regained motor skills and were able to walk again. Six months later, they showed no sign of relapsing.

The findings, published in the journal Stem Cell Reports, suggest the mice experienced at least a partial reversal of their symptoms.

A similar outcome in humans could help patients in potentially disabling stages of the disease for which there are no treatments.

“This result opens up a whole new area of research for us to figure out why it worked,” said Dr Jeanne Loring, a co-author of the paper and director of the centre for regenerative medicine at The Scripps Research Institute in La Jolla, California. “We’ve long forgotten our original plan.”

MS is an auto-immune condition caused by the body’s own defences attacking myelin, the fatty insulation surrounding nerve fibres.

As myelin is stripped away, nerve impulses can no longer be transmitted properly, leading to symptoms ranging from mild tingling to full-blown paralysis.

Drugs that dampen the immune system can slow early forms of the disease, but little can be done for patients in the later stages.

Members of the research team believe their success may be linked to the way the stem cells were grown in an unusually uncrowded lab dish.

This led to stem cells that were highly potent, with an enhanced ability to mature and develop.

Chemical signals from the stem cells instructed each mouse’s own cells to repair the damage caused by MS, the scientists said.

One signal was identified as a protein called TGF-beta, raising the prospect of delivering a similar therapy in the form of a drug.

“Rather than having to engraft stem cells into a patient, which can be challenging from a medical standpoint, we might be able to develop a drug that can be used to deliver the therapy much more easily,” said Professor Lane.

Dr Sorrel Bickley of the MS Society said: “This is an interesting, early-stage study that’s given scientists new ideas for future research into potential MS therapies. It’s not currently being planned for testing in people, but it’s a useful avenue for scientists to explore – we look forward to seeing how this area of research develops.”

PA

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in